The implantable cardioverter defibrillator: its history, current psychological impact and future

References

• Turakhia M, Tseng ZH. Sudden cardiac death: epidemiology, mechanisms, and therapy. Curr. Probl. Cardiol.32(9), 501–546 (2007).
   PubMedGoogle Scholar
• Kenny T. The Nuts and Bolts of ICD Therapy. Blackwell Publishing, MA, USA (2006).
   Google Scholar
• Implantable Cardioverter Defibrillator Therapy: the Engineering–Clinical Interface. Kroll MW, Lehmann MH (Eds). Kluwer Academic Publishers, MA, USA (1996).
   Google Scholar
• Implantable Cardioverter Defibrillator. Singer I (Ed.). Futura Publishing Company, Inc., Armonk, NY, USA (1991).
   Google Scholar
• Lown B, Axelrod P. Implanted standby defibrillators. Circulation46(4), 637–679 (1972).
   PubMed Web of Science ®Google Scholar
• Cardiac pacing and ICDs (4th Edition). Ellenbogen KA, Wood MA (Eds). Blackwell Publishing, MA, USA (2005).
   Google Scholar
• Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann. Intern. Med.138(6), 445–452 (2003).
   PubMed Web of Science ®Google Scholar
• Mirowski M. The automatic implantable cardioverter-defibrillator: an overview. J. Am. Coll. Cardiol.6(2), 461–466 (1985).
   PubMed Web of Science ®Google Scholar
• Crisp AH, Stonehill E. Aspects of the psychological status of patients treated with cardiac pacemakers. Postgrad. Med. J.45(525), 423–427 (1969).
   PubMedGoogle Scholar
• Dlin BM, Fischer HK, Huddell B. Psychologic adaptation to pacemaker and open heart surgery. Arch. Gen. Psychiatry19(5), 599–610 (1968).
   PubMedGoogle Scholar
• Dlin BM, Winters W Jr, Fischer HK, Koch P. Psychological adaptation to pacemaker following cardiac arrest. Psychosomatics7(2), 73–80 (1966).
   PubMedGoogle Scholar
• Fricchione GL, Vlay SC. Psychiatric aspects of patients with malignant ventricular arrhythmias. Am. J. Psychiatry143(12), 1518–1526 (1986).
   PubMedGoogle Scholar
• Kowey PR. The calamity of cardioversion of conscious patients. Am. J. Cardiol.61(13), 1106–1107 (1988).
   PubMedGoogle Scholar
• Wallace RL, Sears SF Jr, Lewis TS, Griffis JT, Curtis A, Conti JB. Predictors of quality of life in long-term recipients of implantable cardioverter defibrillators. J. Cardiopulm. Rehabil.22(4), 278–281 (2002).
   PubMedGoogle Scholar
• Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br. J. Health Psychol.8(Pt 2), 165–178 (2003).
   PubMedGoogle Scholar
• Sears SF, Conti JB, Curtis AB, Saia TL, Foote R, Wen F. Affective distress and implantable cardioverter defibrillators: cases for psychological and behavioral interventions. Pacing Clin. Electrophysiol.22(12), 1831–1834 (1999).
   PubMedGoogle Scholar
• Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. Pacing Clin. Electrophysiol.12(2), 366–373 (1989).
   PubMedGoogle Scholar
• Lemon J, Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol. Health Med.12(2), 163–171 (2007).
   PubMedGoogle Scholar
• Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung24(4), 281–291 (1995).
   PubMed Web of Science ®Google Scholar
• Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the cardiac arrest study Hamburg (CASH). Circulation102(7), 748–754 (2000).
   PubMed Web of Science ®Google Scholar
• Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG patch trial. Pacing Clin. Electrophysiol.22(9), 1305–1313 (1999).
   PubMedGoogle Scholar
• Irvine J, Dorian P, Baker B et al. Quality of life in the canadian implantable defibrillator study (CIDS). Am. Heart J.144(2), 282–289 (2002).
   PubMed Web of Science ®Google Scholar
• Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am. Heart J.127(4 Pt 2), 1179–1184 (1994).
   PubMedGoogle Scholar
• Neel M. Posttraumatic stress symptomatology in patients with automatic implantable cardioverter defibrillators: nature and intervention. Int. J. Emerg. Ment. Health.2(4), 259–263 (2000).
   PubMedGoogle Scholar
• Hamner M, Hunt N, Gee J, Garrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics40(1), 82–85 (1999).
   PubMedGoogle Scholar
• Shemesh E, Koren-Michowitz M, Yehuda R et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics47(3), 231–239 (2006).
   PubMed Web of Science ®Google Scholar
• Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adelet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin. Electrophysiol.29(6), 619–626 (2006).
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol. Psychiatry54(3), 241–247 (2003).
   PubMed Web of Science ®Google Scholar
• Whang W, Albert CM, Sears SF et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the triggers of ventricular arrhythmias (TOVA) study. J. Am. Coll. Cardiol.45(7), 1090–1095 (2005).
   PubMed Web of Science ®Google Scholar
• Luyster FS, Hughes JW, Waechter D, Josephson R. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom. Med.68(5), 794–800 (2006).
   PubMed Web of Science ®Google Scholar
• Goodman M, Hess B. Could implantable cardioverter defibrillators provide a human model supporting the learned helplessness theory of depression? Gen. Hosp. Psychiatry21(5), 382–385 (1999).
   PubMed Web of Science ®Google Scholar
• Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart87(5), 488–493 (2002).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Denollet J. Type D personality, cardiac events, and impaired quality of life: a review. Eur. J. Cardiovasc. Prev. Rehabil.10(4), 241–248 (2003).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom. Med.66(5), 714–719 (2004).
   PubMed Web of Science ®Google Scholar
• Francis J, Johnson B, Niehaus M. Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol. J.6(3), 173–181 (2006).
   PubMedGoogle Scholar
• Passman R, Subacius H, Ruo B et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch. Intern. Med.167(20), 2226–2232 (2007).
   PubMedGoogle Scholar
• Badger JM, Morris PL. Observations of a support group for automatic implantable cardioverter-defibrillator recipients and their spouses. Heart Lung18(3), 238–243 (1989).
   PubMed Web of Science ®Google Scholar
• Molchany CA, Molchany CA, Peterson KA. The psychosocial effects of support group intervention on AICD recipients and their significant others. Prog. Cardiovasc. Nurs.9(2), 23–29 (1994).
   PubMedGoogle Scholar
• Sneed NV, Finch NJ, Leman RB. The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung23(4), 317–322 (1994).
   PubMedGoogle Scholar
• Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart89(2), 155–160 (2003).
   PubMed Web of Science ®Google Scholar
• Frizelle DJ, Lewin RJ, Kaye G et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br. J. Health Psychol.9(Pt 3), 381–392 (2004).
   PubMedGoogle Scholar
• Chevalier P, Cottraux J, Mollard E et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am. Heart J.151(1), 191 (2006).
   PubMedGoogle Scholar
• Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients’ long-term adjustment to the ICD: a prospective study. Pacing Clin. Electrophysiol.23(4 Pt 1), 450–456 (2000).
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Van Den Broek K, Sears SF. Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. PACE30, 1–9 (2007).
   Google Scholar
• Sears SF, Sowell LD, Kuhl EA et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin. Electrophysiol.30(7), 858–864 (2007).
   PubMedGoogle Scholar
• Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the florida patient acceptance survey. J. Cardiovasc. Electrophysiol.16(4), 384–390 (2005).
   PubMed Web of Science ®Google Scholar
• Agard A, Lofmark R, Edvardsson N, Ekman I. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation. J. Med. Ethics33(9), 514–518 (2007).
   PubMedGoogle Scholar
• Shiyovich A, Ben Zion IZ, Plakht Y, Amit G, Grosbard A, Katz A. Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients – with and without shock delivery. Harefuah146(8), 594–598, 647 (2007).
   PubMedGoogle Scholar
• Shea JB. Quality of life issues in patients with implantable cardioverter defibrillators: driving, occupation, and recreation. AACN Clin. Issues15(3), 478–489 (2004).
   PubMedGoogle Scholar
• Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung33(3), 176–182 (2004).
   PubMedGoogle Scholar
• Sowell LV, Kuhl EA, Sears SF et al. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. J. Womens Health (Larchmt)15(7), 830–835 (2006).
   PubMedGoogle Scholar
• Gibson DP, Kuntz KK, Levenson JL et al. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace10(5), 540–544 (2008).
   PubMedGoogle Scholar
• Sears SF Jr, Conti JB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am. J. Cardiol.98(4), 565–567 (2006).
   PubMedGoogle Scholar
• Rogers EM. Diffusion of Innovations (5th Edition). Free Press, Simon & Schuster, Inc., NY, USA (2008).
   Google Scholar
• Fenn J, Linden A. Gartner’s Hype Cycle Special Report for 2005. Document G00130115. Gartner Inc., CT, USA 1–7 (2003).
   Google Scholar
• Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Lampert R. Implantable cardioverter-defibrillator use and benefit in women. Cardiol. Rev.15(6), 298–303 (2007).
   PubMedGoogle Scholar
• Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom. Med.66(6), 898–902 (2004).
   PubMed Web of Science ®Google Scholar
• Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J. Interv. Card. Electrophysiol.22(1), 65–70 (2008).
   PubMedGoogle Scholar
• Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA298(13), 1517–1524 (2007).
   PubMed Web of Science ®Google Scholar
• Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA298(13), 1525–1532 (2007).
   PubMed Web of Science ®Google Scholar
• Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH. Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death. Europace8(12), 1054–1056 (2006).
   PubMed Web of Science ®Google Scholar
• Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am.J. Med.119(2), 167.E17–E21 (2006).
   Google Scholar
• Stanley A, DeLia D, Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants. J. Natl Med. Assoc.99(3), 201–207 (1996).
   Google Scholar
• Thomas KL, Al-Khatib SM, Kelsey RC 2nd et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35%. Am. J. Cardiol.100(6), 924–929 (2007).
   PubMed Web of Science ®Google Scholar
• Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J. Am. Coll. Cardiol.45(1), 72–78 (2005).
   PubMedGoogle Scholar
• Sowell LV, Sears SF Jr, Walker RL, Kuhl EA, Conti JB. Anxiety and marital adjustment in patients with implantable cardioverter defibrillator and their spouses. J. Cardiopulm. Rehabil. Prev.27(1), 46–49 (2007).
   PubMedGoogle Scholar
• Walker RL, Campbell KA, Sears SF et al. Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin. Cardiol.27(10), 543–546 (2004).
   PubMedGoogle Scholar
• Urizar GG Jr, Sears SF Jr, Handberg E, Conti JB. Psychosocial intervention for a geriatric patient to address fears related to implantable cardioverter defibrillator discharges. Psychosomatics45(2), 140–144 (2004).
   PubMedGoogle Scholar
• DeMaso DR, Lauretti A, Spieth L et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am. J. Cardiol.93(5), 582–587 (2004).
   PubMed Web of Science ®Google Scholar
• Kuhl EA, Sears SF, Conti JB. Using computers to improve the psychosocial care of implantable cardioverter defibrillator recipients. Pacing Clin. Electrophysiol.29(12), 1426–1433 (2006).
   PubMedGoogle Scholar